Small Molecule Pharmaceuticals #nutri #pharma


Posted On May 20 2017 by

#merck pharma

#

Small Molecule Pharmaceuticals

High-Quality Products and Services for Small Molecules

Developing a new pharmaceutical drug is a complex and challenging process. As the leader in high-quality products and services for the chemical and pharmaceutical industries, we offer everything you need to optimize development and reduce time to market for your therapeutic small molecules.

And with our comprehensive EMPROVE® dossiers we provide detailed, usage-specific documentation for more than 400 pharma raw materials that includes information on manufacturing, test methods, purity and stability data, helping you to successfully navigate regulatory challenges to the release of your small molecules.

  • A continually updated portfolio for evolving markets and regulatory requirements
  • A wide range of customer-centric services
  • Tailor-made production quantities on a global scale
  • Expertise and state-of-the-art equipment backed by a complete matrix of production technologies capable of fulfilling more than 95% of all common chemical reactions
  • Full service throughout the entire development chain supporting you in chemical as well as regulatory aspects
  • cGMP-certified and FDA-inspected development and production sites
  • API Synthesis
  • Bulk API
  • Purification of Pharm Drugs
  • Formulation

News Releases

Merck will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.

Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing

Merck is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.

Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing

Merck has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand Merck’s excipients portfolio.

Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing

Merck has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.

Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing





Last Updated on: May 20th, 2017 at 7:09 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *